CORC  > 上海大学
QSAR studies on pyrrolidine amides derivatives as DPP-IV inhibitors for type 2 diabetes
Yang, Xiaoyan[1]; Li, Minjie[2]; Su, Qiang[3]; Wu, Milin[4]; Gu, Tianhong[5]; Lu, Wencong[6]
刊名MEDICINAL CHEMISTRY RESEARCH
2013
卷号22页码:5274-5283
关键词Pyrrolidine amides derivatives QSAR Gaussian program mRMR-SFB-SVR DPP-IV inhibitors
ISSN号1054-2523
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2289320
专题上海大学
作者单位1.[1]Shanghai Univ, Coll Sci, Dept Chem, Shanghai 200444, Peoples R China.
2.[2]Shanghai Univ, Coll Sci, Dept Chem, Shanghai 200444, Peoples R China.
3.[3]Shanghai Univ, Sch Mat Sci & Engn, Shanghai 200072, Peoples R China.
4.[4]Shanghai Univ, Coll Sci, Dept Chem, Shanghai 200444, Peoples R China.
5.[5]Shanghai Univ, Sch Mat Sci & Engn, Shanghai 200072, Peoples R China.
6.[6]Shanghai Univ, Coll Sci, Dept Chem, Shanghai 200444, Peoples R China.
推荐引用方式
GB/T 7714
Yang, Xiaoyan[1],Li, Minjie[2],Su, Qiang[3],et al. QSAR studies on pyrrolidine amides derivatives as DPP-IV inhibitors for type 2 diabetes[J]. MEDICINAL CHEMISTRY RESEARCH,2013,22:5274-5283.
APA Yang, Xiaoyan[1],Li, Minjie[2],Su, Qiang[3],Wu, Milin[4],Gu, Tianhong[5],&Lu, Wencong[6].(2013).QSAR studies on pyrrolidine amides derivatives as DPP-IV inhibitors for type 2 diabetes.MEDICINAL CHEMISTRY RESEARCH,22,5274-5283.
MLA Yang, Xiaoyan[1],et al."QSAR studies on pyrrolidine amides derivatives as DPP-IV inhibitors for type 2 diabetes".MEDICINAL CHEMISTRY RESEARCH 22(2013):5274-5283.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace